Full Press Release Details
About Bio-Techne Corporation (NASDAQ: TECH ) Contact: David Clair , Vice President, Investor Relations [email protected] 612-656-441
SOURCE Bio-Techne Corporation
TECH
BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY Bio-Techne Corporation (NASDAQ: TECH) today announced the opening of its new 52,000 square foot state-of-the-art product innovation and manufacturing ...
Key Takeaway: About Bio-Techne Corporation (NASDAQ: TECH ) Contact: David Clair , Vice President, Investor Relations [email protected] 612-656-441
SOURCE Bio-Techne Corporation
21 %